Transcriptomics

Dataset Information

0

Inducible XIST-mediated trisomy 21 correction uncovers a USP16-p16 senescence axis driving epileptogenesis in Down syndrome


ABSTRACT: Down syndrome (DS), caused by human chromosome 21 (HSA21) trisomy, carries elevated epilepsy risk with unknown mechanisms. We integrated clinical epidemiology, fetal brain single-nucleus RNA sequencing, patient-derived induced pluripotent stem cell (iPSC) models, cerebral organoids, and in vivo chimeric mice to dissect this link. Clinical analysis of 1,365 DS individuals exhibited an age-stratified epilepsy prevalence pattern, with higher rates in older children. Fetal brain transcriptomes revealed neurogenesis defects, aging-related signatures, synaptic/metabolic dysregulation. We engineered an inducible XIST-mediated extra HSA21 silencing system in female DS iPSCs, showing HSA21 dosage correction reduced neural progenitor cell (NPC) senescence markers and neuronal hyperexcitability. Transcriptomic screening pinpointed USP16 as a key pro-aging candidate. Moreover, USP16 suppression and the senolytic combination dasatinib/quercetin reduced senescence-linked and hyperexcitability-associated readouts, supporting a USP16-p16-NPC aging axis as a therapeutic target for DS-associated epilepsy, with broader implications for aging-linked neurological disorders.

ORGANISM(S): Homo sapiens

PROVIDER: GSE322851 | GEO | 2026/03/29

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
GSE322851_counts.txt.gz Txt
Items per page:
1 - 2 of 2

Similar Datasets

2026-03-29 | GSE324211 | GEO
| PRJNA265376 | ENA
2022-08-16 | GSE207441 | GEO
2014-05-02 | E-GEOD-52899 | biostudies-arrayexpress
2021-07-20 | GSE160485 | GEO
2014-05-02 | GSE52899 | GEO
2021-07-20 | GSE160388 | GEO
2023-11-01 | GSE160818 | GEO
2020-03-04 | PXD016458 | Pride
2015-12-30 | GSE62823 | GEO